Summary & Overview
HCPCS Level II C1771: Repair Device for Urinary Incontinence, Sling Graft
HCPCS Level II code C1771 denotes a repair device for urinary incontinence that includes a sling graft. The code is relevant to hospitals, ambulatory surgery centers, and payers managing coverage of surgical implants used in stress urinary incontinence repairs. Nationally, sling graft devices are a common component of surgical treatment pathways for patients with physiologic stress or pelvic floor dysfunction, making clear coding essential for claims processing, device tracking, and policy application.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of coding placement and clinical context, typical sites of service where C1771 is billed, and the payer landscape relevant to device reimbursement and coverage. The publication outlines benchmarks and policy-relevant considerations tied to implantable urinary sling graft devices, clarifies common modifiers and billing practices (where provided), and situates the code within surgical service lines. Practical implications for revenue cycle and clinical documentation are described at a national level. Data not available in the input are noted where applicable.
Billing Code Overview
HCPCS Level II code C1771 describes a repair device, urinary, incontinence, with sling graft. This item is used in procedures addressing urinary incontinence where a sling graft device is implanted or utilized to support the urethra or bladder neck.
-
Service Type: Surgical implant/device for urinary incontinence repair
-
Typical Site of Service: Hospital outpatient department or ambulatory surgery center (ASC)
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A 58-year-old woman with symptomatic stress urinary incontinence refractory to conservative measures (pelvic floor physical therapy, pessary) presents for surgical management. She reports urine leakage with coughing and exertion despite behavioral therapies and has failed trial of pelvic floor strengthening. Preoperative evaluation includes urodynamic testing, urinalysis, and assessment for pelvic organ prolapse. The patient is scheduled for a sling revision/repair using a sling graft device to correct recurrent or persistent incontinence related to prior sling failure or erosion.
The clinical workflow includes preoperative counseling and informed consent, anesthesia evaluation (general or regional), operative placement or revision/repair of the urinary incontinence sling with graft material, intraoperative cystoscopy to confirm bladder integrity, and postoperative monitoring for voiding dysfunction, urinary retention, infection, or graft exposure. Typical follow-up visits occur at 2 weeks and 6 weeks to assess healing and continence outcome. This procedure is typically performed in an outpatient ambulatory surgery center or hospital outpatient department; inpatient admission is uncommon unless significant comorbidity or complications occur.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 | Increased procedural services | Use when work or complexity significantly exceeds typical for the procedure (document justification). |